… treatment of patients with severe COVID-19 (including rational selection of therapeutic agents,
timing of the treatment and target subgroups of patients with COVID-19)… severe COVID-19 …

… mortality and need of intubation among COVID-19 patients. Furthermore, the beneficial use
… value in COVID-19 and the basis of immunological reactivity during COVID-19, with a focus …

… coronavirus disease 19 (COVID-19). Like the better known TMA syndromes, this COVID-19-…
for a disease model of complement-mediated TMA and important implications for treatment. …

… of COVID-19, its comorbidities, and mechanistic considerations for future therapies. While
COVID-19 … (RAAS) inhibitors might be beneficial in COVID-19. Initial immune and inflammatory …

… and COVID-19 and to prevent the transmission of coronavirus. The COVID-19 pandemic …
health policies globally, as it requires novel treatment and prevention strategies to adapt for the …

… However, since COVID-19 is a multisystemic disease that … follow-up of all patients with
COVID-19, even those considered … complications due to COVID-19 with post-COVID syndrome, …

… treatment implications, and provide a roadmap for further research on long-term psychiatric
and cognitive impairment after COVID-19… on acute COVID-19 infection and treatment, and …

… of COVID-19 multi-system disease starting from diagnostic evaluation, continuing with
innovative classification of phases and proposing sequential adapted pharmacological treatment. …

… , Collins not only did not provide any genetic treatment for COVID-19, he presented “evidence
of make- beliefs” and misled the world with the natural origin of 2019-nCoV [29]…

… The early treatment is under evaluation in some clinical trials (US National Library of …
corticosteroids in the treatment of patients with non-severe COVID-19 as the treatment brought no …